Status:
UNKNOWN
Efficacy Comparison of Tamoxifen and Tamoxifen With Antioxidants on Semen Quality of Male With Idiopathic Infertility
Lead Sponsor:
Sharif Medical Research Center
Conditions:
Oligoasthenoteratozoospermia
Male Infertility
Eligibility:
MALE
Phase:
PHASE2
Brief Summary
Objective of the study is to compare the efficacy of tamoxifen alone \& tamoxifen with antioxidant on semen quality of infertile male with abnormal parameters (sperm count, motility, vitality, morphol...
Detailed Description
Infertility is considered as the most important issue among the married couples and it represents major clinical problems affecting people not just medically but also psychologically . Infertility af...
Eligibility Criteria
Inclusion
- \- All infertile male with idiopathic infertility and abnormal semen analysis.
Exclusion
- 1\. Leukocytospermia i.e. significant WBCs seen in the semen, 2. Severe oligospermia (sperm count \<5 million per ml),
Key Trial Info
Start Date :
October 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT05200663
Start Date
October 15 2021
End Date
October 1 2022
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sharif Medical And Dental College
Lahore, Punjab Province, Pakistan, 54000